Ingevity Corporation

NYSE:NGVT Stok Raporu

Piyasa değeri: US$2.7b

Ingevity Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Ingevity şirketinin kazançları yıllık ortalama -59.3% oranında azalırken, Chemicals sektörünün kazançları yıllık 0.6% oranında artan oldu. Gelirler yıllık ortalama 0.8% oranında azalan oldu.

Anahtar bilgiler

-59.33%

Kazanç büyüme oranı

-59.04%

EPS büyüme oranı

Chemicals Sektör Büyümesi12.93%
Gelir büyüme oranı-0.80%
Özkaynak getirisi-506.06%
Net Marj-12.87%
Sonraki Kazanç Güncellemesi07 May 2026

Yakın geçmiş performans güncellemeleri

Recent updates

NGVT: Future P/E Will Reflect Margin Resilience And Impairment Charge Impact

Analysts have increased their price target for Ingevity to $80.50 from $79.25, citing updated assumptions on long term revenue growth, profit margin resilience, and future P/E levels reflected in recent research, including the Wells Fargo target increase. Analyst Commentary Recent research behind the new US$80.50 price target focuses on refreshed assumptions for long term revenue trends, margin resilience, and the P/E level that investors may be willing to ascribe to Ingevity over time.

NGVT: Future P/E Will Depend On Margin Execution And Impairment Fallout

Analysts have raised their price target on Ingevity by $5 to $79.25, citing updated assumptions regarding discount rates, long-term revenue growth, profit margins, and future P/E expectations. Analyst Commentary Analysts raising the price target to $79.25 are updating their models to reflect changes in discount rates, long term revenue assumptions, profit margins, and future P/E expectations.

NGVT: Higher P/E Will Rely On Future Margin Delivery

Analysts have lifted their price target on Ingevity by $5 to $79.25, citing updated assumptions on discount rates, long term revenue growth, profit margins, and future P/E, which support a slightly higher valuation outlook. Analyst Commentary Bullish Takeaways Bullish analysts see the higher price target as consistent with updated assumptions on discount rates and long term revenue growth, which they believe better reflect the company’s current risk profile and earnings potential.

NGVT: Higher P/E Outlook Will Depend On Margin Execution

Analysts have raised their price target on Ingevity by $8.50 to $79.25, citing updated views on revenue growth, profit margins, and an expected higher future P/E multiple. Analyst Commentary Recent Street research has focused on how Ingevity might justify a higher valuation, with specific attention on revenue trends, profitability, and the potential for the shares to support a richer P/E multiple over time.

NGVT: Updated P/E Assumptions And Buybacks Will Shape Balanced Outlook

Analysts have raised their price target on Ingevity by $5 to $70.75, citing updated assumptions around discount rates and future P/E as the main factors behind this revised view. Analyst Commentary Analysts framing the new US$70.75 price target are focusing less on short term headlines and more on what updated discount rate and P/E assumptions imply for Ingevity's risk profile and execution needs.

NGVT: Share Repurchases And Battery Materials License Will Guide Balanced Outlook

Analysts have raised their price target on Ingevity from US$69.50 to US$70.75, citing updated assumptions around discount rates, revenue trends, profit margins and future P/E expectations. Analyst Commentary Analysts who support the higher price target describe it as a fine tuning of their models rather than a wholesale rethink.

NGVT: Buybacks And Battery Materials License Will Shape Balanced Outlook

Analysts have maintained their fair value estimate for Ingevity at US$69.50, with only minor adjustments to inputs such as the discount rate and long-term P/E assumptions. These changes reflect updated modeling rather than a change in conviction.

NGVT: Battery Additives And Buybacks Will Shape Balanced Long-Term Outlook

Analysts have adjusted their price target on Ingevity to US$69.50. This reflects updated views on the discount rate, revenue outlook, profit margins and future P/E assumptions.

NGVT: Future Battery Materials Role Will Drive Long-Term Upside Despite Margin Reset

Analysts have modestly raised their price target on Ingevity by about $1.25 to approximately $69.50. They cite a lower perceived discount rate and an improving revenue trajectory, which more than offset concerns about a structurally lower profit margin and a higher future valuation multiple.

NGVT: Future Battery Materials Role Will Drive Stronger Long Term Upside Potential

Analysts have nudged their price target on Ingevity higher from $65.25 to $68.25, citing a modestly richer future earnings multiple that more than offsets slightly softer revenue growth and margin assumptions. What's in the News Ingevity announced that Executive Vice President and Chief Financial Officer Mary Dean Hall will transition from her role effective May 1, 2026, and remain in an advisory capacity for one year, as part of a planned leadership change.

Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

Sep 30
Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

Does Ingevity (NYSE:NGVT) Have A Healthy Balance Sheet?

Sep 06
Does Ingevity (NYSE:NGVT) Have A Healthy Balance Sheet?

Ingevity: No Specialty Play, Awaiting External Drivers

Sep 05

Portfolio Repositioning And Engineered Additives Will Create A Sustainable Future

Consensus analyst price targets for Ingevity have risen to $65.25, reflecting increased confidence in continued earnings and free cash flow growth following a strong Q2 beat and improved operational outlook. Analyst Commentary Q2 earnings beat, demonstrating stronger-than-expected financial performance.

Portfolio Repositioning And Engineered Additives Will Create A Sustainable Future

The upward revision in Ingevity's revenue growth forecasts from 2.6% to 3.7% per annum has outweighed the impact of a higher discount rate, resulting in an increased consensus analyst price target from $54.25 to $57.00. What's in the News Ingevity Corporation maintained its earnings guidance for 2025, expecting sales between $1.25 billion and $1.40 billion.

Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Jun 27
Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Subdued Growth No Barrier To Ingevity Corporation (NYSE:NGVT) With Shares Advancing 33%

May 28
Subdued Growth No Barrier To Ingevity Corporation (NYSE:NGVT) With Shares Advancing 33%
User avatar

Premium Markets Will Secure Long Term Value

Expansion into premium specialty chemicals and advanced materials is increasing margins and positioning for growth as sustainability trends and vehicle electrification accelerate.

Why We're Not Concerned Yet About Ingevity Corporation's (NYSE:NGVT) 32% Share Price Plunge

Apr 05
Why We're Not Concerned Yet About Ingevity Corporation's (NYSE:NGVT) 32% Share Price Plunge

Ingevity (NYSE:NGVT) Has A Somewhat Strained Balance Sheet

Feb 20
Ingevity (NYSE:NGVT) Has A Somewhat Strained Balance Sheet

Ingevity Corporation (NYSE:NGVT) Shares Could Be 49% Below Their Intrinsic Value Estimate

Jan 16
Ingevity Corporation (NYSE:NGVT) Shares Could Be 49% Below Their Intrinsic Value Estimate

What Ingevity Corporation's (NYSE:NGVT) 32% Share Price Gain Is Not Telling You

Nov 07
What Ingevity Corporation's (NYSE:NGVT) 32% Share Price Gain Is Not Telling You

Is Ingevity (NYSE:NGVT) A Risky Investment?

Oct 13
Is Ingevity (NYSE:NGVT) A Risky Investment?

Ingevity Corporation's (NYSE:NGVT) Prospects Need A Boost To Lift Shares

Sep 08
Ingevity Corporation's (NYSE:NGVT) Prospects Need A Boost To Lift Shares

Ingevity: The Risk-Reward Ratio Is Still Unfavorable

Aug 27

Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 03
Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky

Jul 13
Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky

Should You Investigate Ingevity Corporation (NYSE:NGVT) At US$45.90?

Jun 14
Should You Investigate Ingevity Corporation (NYSE:NGVT) At US$45.90?

Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?

Apr 18
Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?

Is Ingevity (NYSE:NGVT) A Risky Investment?

Mar 22
Is Ingevity (NYSE:NGVT) A Risky Investment?

What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?

Jan 23
What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?

Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares

Jan 04
Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares

These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Nov 10
These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Gelir ve Gider Dağılımı

Ingevity nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

NYSE:NGVT Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Dec 251,168-15017128
30 Sep 251,382-36117731
30 Jun 251,383-35417130
31 Mar 251,350-35416329
31 Dec 241,200-12115825
30 Sep 241,309-25816325
30 Jun 241,421-28016527
31 Mar 241,640-11218330
31 Dec 231,21610616225
30 Sep 231,70412719632
30 Jun 231,74017721032
31 Mar 231,67820220732
31 Dec 221,66821219830
30 Sep 221,62122519130
30 Jun 221,51614618129
31 Mar 221,45413017927
31 Dec 211,39211817926
30 Sep 211,38113516925
30 Jun 211,33620916024
31 Mar 211,24818515123
31 Dec 201,21618115023
30 Sep 201,19418015322
30 Jun 201,22217015921
31 Mar 201,30420616321
31 Dec 191,29318416320
30 Sep 191,26818215820
30 Jun 191,21917115221
31 Mar 191,17516114522
31 Dec 181,13416913322
30 Sep 181,08516912522
30 Jun 181,03715311621
31 Mar 1898913810720
31 Dec 1797212710720
30 Sep 179549410419
30 Jun 179425310318
31 Mar 179274510018
31 Dec 16908359618
30 Sep 16898349313
30 Jun 1690264959
31 Mar 16919661055
31 Dec 15958809317
30 Sep 15999991078
30 Jun 151,0251151088

Kaliteli Kazançlar: NGVT şu anda kârlı değil.

Büyüyen Kar Marjı: NGVT şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: NGVT kârlı değildir ve zararlar son 5 yılda yılda 59.3% oranında artmıştır.

Büyüme Hızlandırma: NGVT 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: NGVT kârlı olmadığından, geçmiş yıl kazanç büyümesinin Chemicals sektörüyle ( 0.1% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: NGVT hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -506.06% ) sahiptir.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/06 01:02
Gün Sonu Hisse Fiyatı2026/05/06 00:00
Kazançlar2025/12/31
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Ingevity Corporation 8 Bu analistlerden 4, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Paretosh MisraBerenberg
John McNultyBMO Capital Markets Equity Research
Jonathan TanwantengCJS Securities, Inc.